| scholarly article | Q13442814 |
| P50 | author | Ye Fang | Q40380259 |
| P2093 | author name string | Ann M Ferrie | |
| P2860 | cites work | Dosage-dependent switch from G protein-coupled to G protein-independent signaling by a GPCR | Q24336882 |
| High-content assays for ligand regulation of G-protein-coupled receptors | Q28185834 | ||
| Transduction of receptor signals by beta-arrestins | Q28246395 | ||
| Optical biosensors in drug discovery | Q34743218 | ||
| Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors | Q35153734 | ||
| Techniques: plasmon-waveguide resonance (PWR) spectroscopy as a tool to study ligand-GPCR interactions | Q35599849 | ||
| Multiple signaling states of G-protein-coupled receptors | Q36138102 | ||
| Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors | Q36160942 | ||
| New concepts in drug discovery: collateral efficacy and permissive antagonism | Q36303814 | ||
| GPCR functional selectivity has therapeutic impact | Q36880909 | ||
| The evasive nature of drug efficacy: implications for drug discovery | Q36894549 | ||
| Optical biosensor differentiates signaling of endogenous PAR1 and PAR2 in A431 cells. | Q40116250 | ||
| Non-invasive optical biosensor for assaying endogenous G protein-coupled receptors in adherent cells. | Q40185924 | ||
| Resonant waveguide grating biosensor for living cell sensing. | Q40269125 | ||
| Characteristics of dynamic mass redistribution of epidermal growth factor receptor signaling in living cells measured with label-free optical biosensors | Q40379956 | ||
| Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells | Q40391976 | ||
| Src-mediated tyrosine phosphorylation of dynamin is required for beta2-adrenergic receptor internalization and mitogen-activated protein kinase signaling | Q40982696 | ||
| Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization | Q41852598 | ||
| Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states | Q42046378 | ||
| Non-invasive Optical Biosensor for Probing Cell Signaling. | Q42122607 | ||
| Pharmacological characterization of CGP 12177 at the human beta(2)-adrenoceptor | Q43263681 | ||
| Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes | Q43901717 | ||
| Plasmon-waveguide resonance studies of ligand binding to the human beta 2-adrenergic receptor | Q44800803 | ||
| Synergistic contributions of the functional groups of epinephrine to its affinity and efficacy at the beta2 adrenergic receptor. | Q44854931 | ||
| Probing the beta2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists | Q46427567 | ||
| Optical biosensor provides insights for bradykinin B(2) receptor signaling in A431 cells | Q46785891 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biosensor | Q669391 |
| P304 | page(s) | 558-564 | |
| P577 | publication date | 2008-01-31 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Label-free optical biosensor for ligand-directed functional selectivity acting on beta(2) adrenoceptor in living cells | |
| P478 | volume | 582 |
| Q35956838 | A generic screening platform for inhibitors of virus induced cell fusion using cellular electrical impedance |
| Q39103103 | A label-free optical biosensor with microfluidics identifies an intracellular signalling wave mediated through the β(2)-adrenergic receptor |
| Q28740731 | Agonist-directed desensitization of the β2-adrenergic receptor |
| Q38082089 | Approaches for probing allosteric interactions at 7 transmembrane spanning receptors |
| Q41863995 | Biased agonism |
| Q38452129 | Compound annotation with real time cellular activity profiles to improve drug discovery |
| Q31148493 | Divergent label-free cell phenotypic pharmacology of ligands at the overexpressed β₂-adrenergic receptors |
| Q33386660 | Duplexed label-free G protein--coupled receptor assays for high-throughput screening |
| Q37670366 | Dynamic mass redistribution analysis of endogenous β-adrenergic receptor signaling in neonatal rat cardiac fibroblasts |
| Q35751575 | Dynamic mass redistribution assays decode surface influence on signaling of endogenous purinergic P2Y receptors. |
| Q33765623 | High-throughput screening for modulators of protein-protein interactions: use of photonic crystal biosensors and complementary technologies |
| Q28478728 | Impedance responses reveal β₂-adrenergic receptor signaling pluridimensionality and allow classification of ligands with distinct signaling profiles |
| Q58687097 | Label-Free Biosensors for Cell Biology |
| Q39594022 | Label-Free Cell Phenotypic Identification of D-Luciferin as an Agonist for GPR35. |
| Q34473007 | Label-Free Receptor Assays |
| Q37681372 | Label-free drug discovery |
| Q39119572 | Label-free integrative pharmacology on-target of drugs at the β(2)-adrenergic receptor |
| Q28709650 | Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family |
| Q39825140 | Label-free optical biosensor for probing integrative role of adenylyl cyclase in G protein-coupled receptor signaling |
| Q37856304 | Label-free screening assays: a strategy for finding better drug candidates |
| Q28477403 | Ligand-directed functional selectivity at the mu opioid receptor revealed by label-free integrative pharmacology on-target |
| Q38031893 | Ligand-receptor interaction platforms and their applications for drug discovery. |
| Q37610141 | Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery. |
| Q42538150 | Multiple tyrosine metabolites are GPR35 agonists |
| Q34343837 | PROBING CANCER SIGNALING WITH RESONANT WAVEGUIDE GRATING BIOSENSORS |
| Q38915989 | PTEN deletion potentiates invasion of colorectal cancer spheroidal cells through 3D Matrigel |
| Q30356283 | Recent Advances in Biosensing With Photonic Crystal Surfaces: A Review |
| Q37366719 | Resonant waveguide grating biosensor-enabled label-free and fluorescence detection of cell adhesion |
| Q34438026 | Resonant waveguide grating imager for live cell sensing. |
| Q33890786 | Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery |
| Q33477573 | Signal transduction profiling using label-free biosensors |
| Q37687356 | Surface plasmon resonance fiber sensor for real-time and label-free monitoring of cellular behavior |
| Q42922733 | The Three Catecholics Benserazide, Catechol and Pyrogallol are GPR35 Agonists |
| Q47685791 | The development of label-free cellular assays for drug discovery |
| Q35264433 | The significance of G protein-coupled receptor crystallography for drug discovery |
| Q37967753 | Theory and applications of surface plasmon resonance, resonant mirror, resonant waveguide grating, and dual polarization interferometry biosensors |
| Q46013288 | Troubleshooting and deconvoluting label-free cell phenotypic assays in drug discovery. |
Search more.